113. 筋ジストロフィー Muscular dystrophy Clinical trials / Disease details

臨床試験数 : 646 / 薬物数 : 471 - (DrugBank : 105) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 170

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05412394 (ClinicalTrials.gov)	April 30, 2021	2/2/2022	Once Weekly Infant Corticosteroid Trial for DMD	Phase-2 Trial of 5mg/kg/Week Prednisolone in Young Boys With DMD	Duchenne Muscular Dystrophy	Drug: Prednisolone	Anne M. Connolly	Ann & Robert H Lurie Children's Hospital of Chicago;Children's Hospital Medical Center, Cincinnati	Recruiting	1 Month	30 Months	Male	26	Phase 4	United States
2	NCT03777319 (ClinicalTrials.gov)	December 5, 2018	10/12/2018	Spironolactone Versus Prednisolone in DMD	A Randomized Open Label Trial of Spironolactone Versus Prednisolonein Corticosteroid-naïve Boys With ...	Muscular Dystrophy, Duchenne	Drug: Spironolactone;Drug: Prednisolone	Kevin Flanigan	Muscular Dystrophy Association	Terminated	4 Years	7 Years	Male	2	Phase 1	United States
3	NCT02167217 (ClinicalTrials.gov)	April 17, 2014	3/2/2014	Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy	Phase 2 Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystro ...	Duchenne Muscular Dystrophy	Drug: Prednisolone	Washington University School of Medicine	Nationwide Children's Hospital;Feinberg School of Medicine, Northwestern University;University of Te ...	Completed	1 Month	30 Months	Male	25	Phase 2	United States

First Previous1Next Last